Skip to content

Clinical trials

Recruiting Alzheimer Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Recruiting Country / region: United States Clear all

241 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20091
20121
20142
20165
20173
20187
20195
20205
202116
202221
202334
202434
202561
202644

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting241

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company8
Bristol-Myers Squibb7
Johns Hopkins University7
Washington University School of Medicine7
Indiana University6
Massachusetts General Hospital6
University of Pennsylvania6
Columbia University5
Mayo Clinic4
Arizona State University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease241
Cognitive Dysfunction83
Dementia78
Parkinson Disease13
Brain Diseases11
Neurodegenerative Diseases11
Frontotemporal Dementia10
Lewy Body Disease10
Nervous System Diseases9
Neurocognitive Disorders9

Trials

Showing 1 to 25 of 241. Each trial links to its page on Pharma Observatory.

141 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.